Literature DB >> 8440465

Inhibition of Bordetella pertussis filamentous hemagglutinin-mediated cell adherence with monoclonal antibodies.

E Leininger1, P G Probst, M J Brennan, J G Kenimer.   

Abstract

Filamentous hemagglutinin (FHA), a 220-kDa protein located on the surface of Bordetella pertussis, is one of the major cell adhesins of this bacterium. We have produced three hybridoma cell lines that express monoclonal antibodies (mAbs) against FHA: X3C, X3E and X4B. The anti-FHA mAbs X3C and X3E reacted with 220-kDa and 98-kDa FHA protein bands on Western blots. The mAb X4B, which reacted with FHA in ELISA, did not bind to FHA in a Western blot assay. All three mAbs seemed to be directed to the same epitope or to epitopes in close proximity as suggested by competition ELISAs. All three mAbs were able to inhibit the adherence of Chinese hamster ovary cells to purified FHA, and they could also inhibit the FHA-mediated agglutination of goose red blood cells. The attachment of B. pertussis to epithelial cell monolayers was inhibited by the mAb X3C. These antibodies are very useful probes to identify the presence of FHA in bordetellae species and in clinical reagents such as pertussis vaccines, and to characterize the functional domains of this important bacterial adhesin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440465     DOI: 10.1111/j.1574-6968.1993.tb05931.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  11 in total

1.  A highly adherent phenotype associated with virulent Bvg+-phase swine isolates of Bordetella bronchiseptica grown under modulating conditions.

Authors:  K B Register; M R Ackermann
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

2.  Effect of hydromechanical stress on cellular antigens of Bordetella pertussis.

Authors:  M E Rodriguez; D F Hozbor; O M Yantorno
Journal:  J Ind Microbiol       Date:  1996-07

3.  Distinct roles of the N-terminal and C-terminal precursor domains in the biogenesis of the Bordetella pertussis filamentous hemagglutinin.

Authors:  G Renauld-Mongénie; J Cornette; N Mielcarek; F D Menozzi; C Locht
Journal:  J Bacteriol       Date:  1996-02       Impact factor: 3.490

4.  Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA.

Authors:  J H Hannah; F D Menozzi; G Renauld; C Locht; M J Brennan
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

5.  Detection and subcellular localization of three Ptl proteins involved in the secretion of pertussis toxin from Bordetella pertussis.

Authors:  F D Johnson; D L Burns
Journal:  J Bacteriol       Date:  1994-09       Impact factor: 3.490

6.  Role of the dermonecrotic toxin of Bordetella bronchiseptica in the pathogenesis of respiratory disease in swine.

Authors:  Susan L Brockmeier; Karen B Register; Tibor Magyar; Alistair J Lax; Gillian D Pullinger; Robert A Kunkle
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

7.  Reduced virulence of a Bordetella bronchiseptica siderophore mutant in neonatal swine.

Authors:  K B Register; T F Ducey; S L Brockmeier; D W Dyer
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs.

Authors:  P Stefanelli; P Mastrantonio; S Z Hausman; M Giuliano; D L Burns
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

9.  Contribution of Bordetella bronchiseptica filamentous hemagglutinin and pertactin to respiratory disease in swine.

Authors:  Tracy L Nicholson; Susan L Brockmeier; Crystal L Loving
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

10.  Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis.

Authors:  F D Menozzi; R Mutombo; G Renauld; C Gantiez; J H Hannah; E Leininger; M J Brennan; C Locht
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.